Hysbysiad contract
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
The Christie NHS Foundation Trust
Wilmslow Road
Manchester
M20 4BX
UK
Person cyswllt: Diane Sinclair
Ffôn: +44 7748624560
E-bost: Diane.Sinclair@nhs.net
NUTS: UKD3
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://www.christie.nhs.uk/
Cyfeiriad proffil y prynwr: https://www.christie.nhs.uk/
I.3) Cyfathrebu
Mae'r dogfennau caffael ar gael ar gyfer mynediad uniongyrchol anghyfyngedig a llawn, yn rhad ac am ddim ar:
https://health-family.force.com/s/Welcome
Gellir cael gwybodaeth ychwanegol o'r cyfeiriad uchod
Rhaid anfon tendrau neu geisiadau i gymryd rhan yn electronig at:
https://health-family.force.com/s/Welcome
Rhaid anfon tendrau neu geisiadau i gymryd rhan i'r cyfeiriad uchod:
Mae cyfathrebu electronig yn gofyn am ddefnyddio offer a dyfeisiau nad ydynt ar gael yn gyffredinol. Mae mynediad uniongyrchol anghyfgyfyngiedig a llawn i'r offer a dyfeisiau hyn yn bosibl, yn rhad ac am ddim, yn:
https://health-family.force.com/s/Welcome
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
Pathology Service Joint Venture
II.1.2) Prif god CPV
85111800
II.1.3) Y math o gontract
Gwasanaethau
II.1.4) Disgrifiad byr
The Trust has worked with a commercial partner in a joint venture (JV) arrangement to deliver a comprehensive pathology service for the last 10 years. Building on this knowledge and experience, the Trust is looking for a new partner that matches its ambitions. <br/><br/>The initial term of the pathology service JV is expected to be for a period of fifteen (15) years with an option to extend by up to five (5) years.<br/><br/>The Trust is looking for a partner that will;<br/><br/>• Provide an exceptional, high-quality service that meets the specialist needs of a comprehensive cancer centre;<br/>• Provide investment for the provision of world class infrastructure;<br/>• Embrace the exciting opportunities presented with the co-location of a world leading oncology research centre; and<br/>• Provide expert guidance along with the creativity and drive to deliver a modern, thriving, truly exceptional pathology service for patients.
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.2) Disgrifiad
II.2.2) Cod(au) CPV ychwanegol
85110000
85111810
II.2.3) Man cyflawni
Cod NUTS:
UKD3
II.2.4) Disgrifiad o’r caffaeliad
The current pathology service provides routine and specialist pathology services with c100 dedicated staff on The Christie Hospital site. The service includes translational biomarker development and supports the Trust’s ambitious Research and Innovation (R&I) programme and clinical trials portfolio. <br/><br/>Demand for testing is increasing year on year reflecting the Trust’s oncology case load. <br/>The Trust seeks a JV pathology partner who is able to deliver the Trust’s strategic ambitions, including accommodation of projected testing growth demand and flexible options for the development of facilities, estate, technology, and changes in clinical pathways. <br/><br/>Vision<br/><br/>To provide a world leading comprehensive pathology service that supports timely and high-quality delivery of patient care - regionally and nationally - and develops an internationally recognised workforce who, with academic and industry partners, deliver a pioneering programme of research and innovation.<br/><br/>Principles/Objectives<br/><br/>The Future Pathology Service should reflect the following principles/objectives:<br/><br/>• Safe, effective, and responsive to the diversity of patient and clinical needs and offers the specialist and integrated pathology services needed to support a regional tertiary cancer centre.<br/>• Delivery of a sustainable future pathology workforce<br/>• alignment with the Trust’s Vision and Values and the objectives of Greater Manchester Cancer.<br/>• Commitment to working as part of Greater Manchester ICS in the delivery of the Core20PLUS5 programme to support the reduction of health inequalities at both national and system level.<br/>• Enabled by a strong digital infrastructure and capability. Adopting digital opportunity and technology advances to deliver more efficient and scalable pathology services.<br/>• A service model that considers The Trust’s local, regional national and international partnerships, including engagement with the Greater Manchester Pathology Network to explore opportunities to support system requirements.<br/>• Delivered through a partnership that has a strategy for profitable growth through expanding test repertoire and customer base.<br/>• Builds upon the Trust’s reputation as an international leader in research and innovation, which is further strengthened by being a partner in the Manchester Cancer Research Centre (MCRC) and Health Innovation Manchester.<br/>• A service with capital investment to provide best in class facilities.<br/>• A service that has education at its core.<br/><br/>The Future Operating Model for Pathology must include:<br/><br/>• An end-to-end comprehensive pathology service<br/>• Blood sciences including haematology, blood transfusion, clinical biochemistry and immunoassay<br/>• On-site essential services laboratory to support time critical and pathway critical services<br/>• Histopathology (including immunohistochemistry and receptor analysis)<br/>• Stem Cell Laboratory<br/>• Point-of-Care Testing <br/>• A future-proof design with activity growth in service expectation factored in – including expansion of on-site and off-site facilities to meet projected demand;<br/>• An agile approach that can respond to evolving technology and operational requirements and provide improvements to the Trust Pathology Estate; <br/>• Training, Development and Education, Research and Innovation <br/>• Positive workplace culture<br/>• IT infrastructure and digital enablement (including Digital Histopathology)<br/>• Best in class equipment and instrumentation<br/><br/>Further information and details about the requirements and scope of the procurement are set out in the Statement of Requirements and supporting information which will be available as part of the procurement documents at https://health-family.force.com/s/Welcome
II.2.5) Meini prawf dyfarnu
Nid pris yw’r unig faen prawf dyfarnu a dim ond yn y dogfennau caffael y mae’r holl feini prawf wedi’u nodi
II.2.6) Gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 240 000 000.00 GBP
II.2.7) Hyd y contract, y cytundeb fframwaith neu’r system brynu ddynamig
Hyd mewn misoedd: 240
Gall y contract hwn gael ei adnewyddu: Ydy
Disgrifiad o’r adnewyddiadau:
The proposed contract is to be let for an initial term of 180 months. There is also an option to extend the Contract by up to a further 60 months following the initial term.
II.2.9) Gwybodaeth am y cyfyngiadau ar nifer yr ymgeiswyr a gaiff eu gwahodd
Nifer yr ymgeiswyr a ragwelir: 3
Meini prawf gwrthrychol ar gyfer dewis y nifer cyfyngedig o ymgeiswyr:
As specified in the SQ/ITPD documentation
II.2.10) Gwybodaeth am amrywiadau
Derbynnir amrywiadau:
Na
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
II.2.14) Gwybodaeth ychwanegol
The estimated value in II.2.6 is based on the existing annual turnover of the JV over the lifetime of the contract.
Section III: Gwybodaeth gyfreithiol, economaidd, ariannol a thechnegol
III.1) Amodau ar gyfer cymryd rhan
III.1.2) Statws economaidd ac ariannol
Meini prawf dethol fel y’u nodir yn y dogfennau caffael
III.1.3) Gallu technegol a phroffesiynol
Meini prawf dethol fel y’u nodir yn y dogfennau caffael
III.2) Amodau sy’n gysylltiedig â’r contract
III.2.1) Gwybodaeth am broffesiwn penodol
PDim ond proffesiwn penodol all gymryd rhan : Ydy
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Deialog Gystadleuol
IV.1.4) Gwybodaeth am leihau nifer yr atebion neu’r tendrwyr yn ystod negodiad neu ddeialog
Troi at weithdrefn fesul cam er mwyn mynd ati’n raddol i leihau nifer yr atebion i’w trafod neu’r tendrau i’w negodi
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Ydy
IV.2) Gwybodaeth weinyddol
IV.2.1) Cyhoeddiad blaenorol mewn perthynas â’r weithdrefn hon
Rhif yr hysbysiad yn OJ S:
2023/S 000-003320
IV.2.2) Terfyn amser i dendrau neu geisiadau i gymryd rhan ddod i law
Dyddiad:
27/11/2023
Amser lleol: 16:00
IV.2.3) Dyddiad amcangyfrifedig ar gyfer anfon gwahoddiadau i dendro neu i gymryd rhan at yr ymgeiswyr a ddewiswyd
Dyddiad:
11/12/2023
IV.2.4) Ym mha iaith/ieithoedd y gellir cyflwyno tendrau neu geisiadau i gymryd rhan
EN
IV.2.6) Yr isafswm cyfnod gofynnol i’r sawl sy’n tendro gynnal y tendr
Hyd mewn misoedd: 12 (o’r dyddiad a nodwyd i dendr ddod i law)
Section VI: Gwybodaeth ategol
VI.1) Gwybodaeth am ailddigwydd
Caffaeliad cylchol yw hwn:
Na
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
The High Court
The Strand
London
WC2A 2LL
UK
Cyfeiriad(au) rhyngrwyd
URL: https://www.judiciary.uk/courts-and-tribunals/high-court/
VI.5) Dyddiad anfon yr hysbysiad hwn
26/10/2023